Inventor · disambiguated record
Kathryn Packman
Also filed as: PACKMAN KATHRYN · PACKMAN KATHRYN E · PACKMAN KATHRYN ELIZABETH
10 granted patents·15 pending applications·45 citations·filing 2011–2023
87Inventor score
Files withHOFFMANN LA ROCHE14JANSSEN PHARMACEUTICA NV5DHINGRA KAPIL3ROCHE GLYCART AG2BOYLAN JOHN FREDERICK1
Top patents by PatentIndex Score
25 records- 0190US11214622B2Antibodies specific for DR5 and methods of useROCHE GLYCART AG·Filed 2018·Granted Jan 4, 2022·6 cites·13 claims
- 0290US9926379B2Bispecific antibodies specific for FAP and DR5, antibodies specific for DR5ROCHE GLYCART AG·Filed 2014·Granted Mar 27, 2018·17 cites·28 claims
- 0388US9486445B2Combination therapy for proliferative disordersHOFFMANN LA ROCHE·Filed 2015·Granted Nov 8, 2016·10 cites·15 claims
- 0480US2023381215A1Novel combination treatment for acute myeloid leukemia (aml)HOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0578US9216170B2Combination therapy for proliferative disordersHOFFMANN LA ROCHE·Filed 2013·Granted Dec 22, 2015·4 cites·13 claims
- 0677US9956243B2Combination treatment for acute myeloid leukemia (AML)HOFFMANN LA ROCHE·Filed 2014·Granted May 1, 2018·2 cites·13 claims
- 0773US8741889B2Method of treating non-small cell lung cancer and colon cancer with gamma-secretase inhibitorBOYLAN JOHN FREDERICK·Filed 2012·Granted Jun 3, 2014·3 cites·15 claims
- 0872US2022031726A1Novel combination treatment for acute myeloid leukemia (aml)HOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 0969US8709419B2Combination therapyDHINGRA KAPIL·Filed 2011·Granted Apr 29, 2014·3 cites·22 claims
- 1068US11738003B2Method for administrationHOFFMANN LA ROCHE·Filed 2020·Granted Aug 29, 2023·0 cites·11 claims
- 1166US2020253999A1Novel combination treatment for acute myeloid leukemia (aml)HOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1262US2016303158A1Novel combination treatment for acute myeloid leukemia (aml)HOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 1361US2019328708A1Method for administrationHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 1461US2023241087A1Methods Of Treating Cancer Using Prmt5 InhibitorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 1558US2023013755A1Inhibitors of bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 1658US2015126575A1Method for administrationHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
- 1756US2013245089A1Method for administrationHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1855US2025302840A1Combination therapiesJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 1953US2024261292A1Combination therapiesJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 2050US11571437B2Methods of treating cancer using PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Feb 7, 2023·0 cites·42 claims
- 2149US2016256529A1Combination therapyHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 2245US9295669B2Combination therapy for proliferative disordersDHINGRA KAPIL·Filed 2011·Granted Mar 29, 2016·0 cites·11 claims
- 2343US2016129033A1Combination of ro5503781 and capecitabine for cancer therapyHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 2443US2016129034A1Combination of ro5503781, capecitabine and oxaliplantin for cancer therapyHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 2539US2012045433A1Combination therapyDHINGRA KAPIL·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kathryn Packman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →